oxymatrin
omt
strong
immunosuppress
agent
use
clinic
mani
year
present
studi
use
plaqu
inhibit
luciferas
report
plasmid
qrtpcr
western
blot
elisa
assay
investig
effect
mechan
omt
influenza
viru
iav
replic
iavinduc
inflamm
vitro
vivo
result
show
omt
excel
antiiav
activ
eight
iav
strain
vitro
omt
could
significantli
decreas
promot
activ
gene
inhibit
iavinduc
activ
akt
mapk
pathway
suppress
express
inflammatori
cytokin
activ
mapk
pathway
could
significantli
antagon
antiiav
activ
omt
vitro
includ
iav
replic
iavinduc
cytopathogen
effect
cpe
furthermor
omt
could
reduc
loss
bodi
weight
significantli
increas
surviv
rate
iavinfect
mice
decreas
lung
index
pulmonari
inflamm
lung
viral
titter
improv
pulmonari
histopatholog
chang
conclus
omt
possess
antiiav
antiinflammatori
activ
mechan
action
may
link
abil
inhibit
iavinduc
activ
mapk
pathway
influenza
viru
iav
often
caus
extens
respiratori
infect
sever
iav
infect
usual
lead
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
aliard
one
main
caus
death
intens
care
unit
icu
high
mortal
rate
current
specif
medicin
avail
manag
aliard
infect
iav
hijack
array
intracellular
signal
cascad
benefit
tlr
rigi
pkcpkr
mapk
signal
pathway
iav
infect
increas
express
phosphoryl
akt
mapk
nuclear
transloc
sever
iavinfect
die
patient
lastingli
highli
express
report
last
activ
detriment
iavinduc
acut
pneumonia
convers
iavinfect
mice
unexpect
surviv
advantag
significantli
lower
viral
titer
less
inflammatori
mediat
fewer
patholog
chang
lung
report
markedli
cluster
site
iavcel
interact
cytomembran
determin
iav
entri
tissu
tropism
express
mapk
activ
inactiv
avian
influenza
viru
induc
sever
oxid
stress
rapidli
lead
ali
signal
mice
report
highli
refractori
iavinduc
ali
antagonist
eritoran
decreas
viral
titer
iavinduc
lethal
activ
also
necessari
effici
replic
iav
sever
inhibitor
signal
effect
suppress
iav
replic
iavinduc
upregul
proinflammatori
cytokin
matrix
metalloproteinas
mmp
moreov
activ
signal
also
essenti
releas
neutrophil
excess
migrat
two
princip
caus
aliard
addit
downstream
cascad
tlr
mapk
pathway
also
requir
iav
infect
prolifer
base
fact
iavinduc
overexpress
tlr
trif
abnorm
nuclear
transloc
essenti
iav
infect
construct
seri
luciferas
report
plasmid
base
promot
gene
nuclear
respons
element
use
plasmid
perform
sever
time
drug
screen
assay
found
sophora
root
sophora
flavescen
aiton
tradit
herbal
medicin
use
antipyret
diuret
anthelmint
agent
china
thousand
year
significantli
inhibit
pathway
oxymatrin
c
h
n
omt
major
activ
compound
sophora
root
report
omt
antioxid
antiinflamm
antiviru
hepatoprotect
immunosuppress
activ
current
extens
employ
treat
viral
hepat
traumat
brain
injuri
acut
pancreat
sepsi
ali
clinic
previou
studi
found
omt
low
concentr
inhibit
iav
infect
vitro
vivo
present
studi
determin
effect
omt
iav
infect
high
concentr
vitro
vivo
investig
mechan
action
omt
mainli
focus
tlr
mapk
signal
pathway
experiment
determin
cytotox
omt
mdck
cell
result
show
omt
significantli
reduc
viabil
cell
concentr
x
r
cc
figur
cytotox
omt
mdck
similar
cell
figur
plaqu
inhibit
assay
found
omt
could
significantli
inhibit
iav
replic
rang
figur
c
x
r
ec
ai
cc
ec
chose
test
concentr
follow
pharmacolog
experi
besid
omt
also
could
significantli
inhibit
infect
determin
sulforhodamin
b
srb
method
ec
respect
figur
moreov
omt
also
could
significantli
inhibit
infect
differ
multipl
infect
moi
figur
final
detect
effect
omt
viru
life
cycl
ie
step
iav
replic
inhibit
perform
timeofaddit
assay
found
omt
could
directli
inactiv
iav
signific
influenc
cell
iav
infect
iav
adsorpt
inhibit
omt
iav
replic
occur
h
post
infect
pi
figur
cytotox
omt
determin
mtt
method
cell
data
shown
mean
sd
n
p
compar
group
b
c
effect
omt
iav
replic
determin
plaqu
inhibit
assay
neg
control
nc
mdck
cell
infect
iav
treat
drug
posit
control
pc
omttreat
group
mdck
cell
infect
iav
treat
ribavirin
omt
respect
moi
incub
time
h
data
shown
mean
sd
five
independ
experi
n
p
compar
nc
group
cytotox
omt
determin
mtt
method
cell
data
shown
mean
sd
n
p
compar
group
b
c
effect
omt
iav
replic
determin
plaqu
inhibit
assay
neg
control
nc
mdck
cell
infect
iav
treat
drug
posit
control
pc
omttreat
group
mdck
cell
infect
iav
treat
ribavirin
omt
respect
moi
incub
time
h
data
shown
mean
sd
five
independ
experi
n
p
compar
nc
group
cytotox
omt
determin
mtt
method
cell
data
shown
mean
sd
n
p
compar
group
b
c
effect
omt
iav
replic
determin
plaqu
inhibit
assay
neg
control
nc
mdck
cell
infect
iav
treat
drug
posit
control
pc
omttreat
group
mdck
cell
infect
iav
treat
ribavirin
omt
respect
moi
incub
time
h
data
shown
mean
sd
five
independ
experi
n
p
compar
nc
group
detect
influenc
omt
activ
tlr
signal
pathway
first
construct
promot
luciferas
report
human
trif
gene
shown
figur
without
iav
infect
omt
alon
could
significantli
decreas
promot
activ
gene
iav
infect
omt
also
could
significantli
decreas
iavinduc
upregul
promot
activ
gene
addit
result
western
blot
assay
also
show
omt
could
significantli
decreas
iavinduc
high
express
gene
cell
figur
detect
influenc
omt
activ
tlr
signal
pathway
first
construct
promot
luciferas
report
human
trif
gene
shown
figur
without
iav
infect
omt
alon
could
significantli
decreas
promot
activ
gene
iav
infect
omt
also
could
significantli
decreas
iavinduc
upregul
promot
activ
gene
addit
result
western
blot
assay
also
show
omt
could
significantli
decreas
iavinduc
high
express
gene
cell
figur
gene
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
dmso
group
p
compar
dmso
viru
vir
group
b
effect
omt
express
gene
determin
western
blot
assay
cell
iav
infect
moi
incub
time
h
data
shown
mean
sd
three
independ
experi
p
compar
dmso
viru
vir
group
concentr
ribavirin
omt
respect
report
iavinduc
activ
rafmekerk
jnk
mapk
signal
pathway
support
iav
infect
addit
also
report
omt
inhibit
activ
pathway
brain
damag
cirrhot
rat
lpsstimul
microgli
cell
gene
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
dmso
group
p
compar
dmso
viru
vir
group
b
effect
omt
express
gene
determin
western
blot
assay
cell
iav
infect
moi
incub
time
h
data
shown
mean
sd
three
independ
experi
p
compar
dmso
viru
vir
group
concentr
ribavirin
omt
respect
report
iavinduc
activ
rafmekerk
jnk
mapk
signal
pathway
support
iav
infect
addit
also
report
omt
inhibit
activ
pathway
brain
damag
cirrhot
rat
lpsstimul
microgli
cell
therefor
also
determin
effect
omt
iavinfect
cell
signal
pathway
show
figur
b
omt
could
significantli
inhibit
iavinduc
phosphoryl
akt
mapk
nuclear
transloc
significantli
iavinduc
phosphoryl
jnk
investig
western
blot
assay
addit
detect
influenc
omt
transcript
downstream
target
gene
purchas
report
plasmid
duplic
respons
element
gggaatttcc
beyotim
institut
biotechnolog
shanghai
china
show
figur
omt
could
significantli
inhibit
transcript
report
plasmid
matter
iav
infect
therefor
also
determin
effect
omt
iavinfect
cell
signal
pathway
show
figur
b
omt
could
significantli
inhibit
iavinduc
phosphoryl
akt
mapk
nuclear
transloc
significantli
iavinduc
phosphoryl
jnk
investig
western
blot
assay
addit
detect
influenc
omt
transcript
downstream
target
gene
purchas
report
plasmid
duplic
respons
element
gggaatttcc
beyotim
institut
biotechnolog
shanghai
china
show
figur
omt
could
significantli
inhibit
transcript
report
plasmid
matter
iav
infect
concentr
ribavirin
omt
respect
moi
incub
time
h
data
shown
mean
sd
three
independ
experi
p
vs
dmso
viru
group
c
influenc
omt
transcript
downstream
target
gene
determin
report
plasmid
assay
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
concentr
ribavirin
omt
respect
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
dmso
group
p
compar
dmso
viru
vir
group
determin
import
tlr
signal
pathway
antiiav
activ
omt
activ
signal
pathway
use
result
show
activ
mapk
activ
anisomycin
activ
pma
could
concentr
ribavirin
omt
respect
moi
incub
time
h
data
shown
mean
sd
three
independ
experi
p
vs
dmso
viru
group
c
influenc
omt
transcript
downstream
target
gene
determin
report
plasmid
assay
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
concentr
ribavirin
omt
respect
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
dmso
group
p
compar
dmso
viru
vir
group
determin
import
tlr
signal
pathway
antiiav
activ
omt
activ
signal
pathway
use
result
show
activ
mapk
activ
anisomycin
activ
pma
could
significantli
antagon
inhibitori
effect
omt
iavinduc
decreas
cell
viabil
determin
srb
method
significantli
counteract
inhibitori
effect
omt
iav
replic
determin
qrtpcr
assay
effect
activ
polyi
c
activ
activ
activ
egf
signific
figur
significantli
antagon
inhibitori
effect
omt
iavinduc
decreas
cell
viabil
determin
srb
method
significantli
counteract
inhibitori
effect
omt
iav
replic
determin
qrtpcr
assay
effect
activ
polyi
c
activ
activ
activ
egf
signific
figur
antagonist
effect
activ
tlr
pathway
antiiav
activ
omt
cell
infect
iav
moi
treat
without
ribavirin
omt
simultan
treat
without
activ
polyi
c
ngml
activ
activ
activ
ngml
erk
activ
egf
ngml
activ
anisomycin
activ
pma
test
dose
activ
determin
accord
previou
report
preliminari
test
h
cell
viabil
determin
srb
method
iav
vrna
level
determin
qrtpcr
assay
b
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
viru
drug
control
iav
infect
induc
product
inflammatori
cytokin
high
level
inflammatori
cytokin
report
contribut
sever
pulmonari
histopatholog
chang
iav
infect
studi
also
determin
influenc
omt
iavmedi
releas
elisa
assay
shown
figur
omt
could
significantli
inhibit
releas
iav
infect
antagonist
effect
activ
tlr
pathway
antiiav
activ
omt
cell
infect
iav
moi
treat
without
ribavirin
omt
simultan
treat
without
activ
polyi
c
ngml
activ
activ
activ
ngml
erk
activ
egf
ngml
activ
anisomycin
activ
pma
test
dose
activ
determin
accord
previou
report
preliminari
test
h
cell
viabil
determin
srb
method
iav
vrna
level
determin
qrtpcr
assay
b
data
shown
mean
sd
three
independ
experi
perform
triplic
p
compar
viru
drug
control
iav
infect
induc
product
inflammatori
cytokin
high
level
inflammatori
cytokin
report
contribut
sever
pulmonari
histopatholog
chang
iav
infect
studi
also
determin
influenc
omt
iavmedi
releas
elisa
assay
shown
figur
omt
could
significantli
inhibit
releas
iav
infect
figur
effect
omt
releas
proinflammatori
cytokin
iav
infect
cell
seed
plate
h
infect
without
iav
moi
ribavirinand
omttreat
group
cell
treat
ribavirin
omt
h
supernat
cell
collect
use
elisa
assay
data
shown
mean
sd
three
independ
experi
three
replic
p
compar
dmso
viru
vir
group
iav
infect
day
mice
start
show
diseas
symptom
ruffl
fur
follow
labor
breath
loss
bodi
weight
day
pi
oseltamivir
mgkgday
pc
omt
mgkgday
treatment
could
significantli
increas
bodi
weight
mice
infect
iav
respect
figur
day
pi
surviv
rate
group
nc
oseltamivir
pc
omt
mgkgday
mgkgday
treat
group
respect
oseltamivir
omt
could
significantli
increas
surviv
rate
mice
infect
iav
figur
addit
omt
oseltamivir
could
significantli
reduc
lung
index
transcript
figur
significantli
reduc
pulmonari
viral
load
determin
day
pi
figur
f
addit
compar
mgkgdayomttr
group
omt
mgkgday
could
reduc
lung
index
viral
titer
though
significantli
figur
f
qrtpcr
assay
iav
vrna
level
significantli
decreas
mgkgday
omttreat
group
figur
furthermor
compar
oseltamivir
mgkgday
omt
significantli
less
inhibitori
effect
lung
index
viral
titer
final
histopatholog
chang
assay
lung
nc
group
show
signific
alveolar
exud
thicken
destruct
alveolar
wall
alveolar
hemorrhag
red
blood
cell
within
alveolar
space
oseltamivir
omt
could
significantli
inhibit
histopatholog
chang
induc
iav
infect
observ
day
pi
figur
figur
effect
omt
releas
proinflammatori
cytokin
iav
infect
cell
seed
plate
h
infect
without
iav
moi
ribavirinand
omttreat
group
cell
treat
ribavirin
omt
h
supernat
cell
collect
use
elisa
assay
data
shown
mean
sd
three
independ
experi
three
replic
p
compar
dmso
viru
vir
group
iav
infect
day
mice
start
show
diseas
symptom
ruffl
fur
follow
labor
breath
loss
bodi
weight
day
pi
oseltamivir
mgkgday
pc
omt
mgkgday
treatment
could
significantli
increas
bodi
weight
mice
infect
iav
respect
figur
day
pi
surviv
rate
group
nc
oseltamivir
pc
omt
mgkgday
mgkgday
treat
group
respect
oseltamivir
omt
could
significantli
increas
surviv
rate
mice
infect
iav
figur
addit
omt
oseltamivir
could
significantli
reduc
lung
index
transcript
figur
significantli
reduc
pulmonari
viral
load
determin
day
pi
figur
f
addit
compar
mgkgdayomttr
group
omt
mgkgday
could
reduc
lung
index
viral
titer
though
significantli
figur
f
qrtpcr
assay
iav
vrna
level
significantli
decreas
mgkgday
omttreat
group
figur
furthermor
compar
oseltamivir
mgkgday
omt
significantli
less
inhibitori
effect
lung
index
viral
titer
final
histopatholog
chang
assay
lung
nc
group
show
signific
alveolar
exud
thicken
destruct
alveolar
wall
alveolar
hemorrhag
red
blood
cell
within
alveolar
space
oseltamivir
omt
could
significantli
inhibit
histopatholog
chang
induc
iav
infect
observ
day
pi
figur
antiiav
activ
omt
vivo
blank
control
bc
mice
infect
iav
sham
intranas
vgm
medium
neg
control
nc
posit
control
pc
omttreat
group
mice
intranas
infect
iav
treat
dmso
oseltamivir
mgkgday
omt
mgkgday
mgkgday
oral
gavag
day
day
pi
respect
chang
bodi
weight
surviv
rate
b
observ
day
n
signific
differ
surviv
rate
analyz
kaplanmei
analysi
logrank
breslow
test
c
lung
index
assess
determin
percent
lung
wet
weight
g
bodi
weight
g
lung
index
lung
wet
weight
g
bodi
weight
g
day
pi
level
lung
homogen
determin
qrtpcr
assay
day
pi
n
e
f
iav
replic
viral
titter
lung
determin
qrtpcr
assay
day
pi
n
data
shown
mean
sd
p
compar
nc
dmso
viru
group
p
compar
pc
dmso
viru
oseltamivir
group
p
compar
omt
mgkgday
group
antiiav
activ
omt
vivo
blank
control
bc
mice
infect
iav
sham
intranas
vgm
medium
neg
control
nc
posit
control
pc
omttreat
group
mice
intranas
infect
mld
iav
treat
dmso
oseltamivir
mgkgday
omt
mgkgday
mgkgday
oral
gavag
day
day
pi
respect
chang
bodi
weight
surviv
rate
b
observ
day
n
signific
differ
surviv
rate
analyz
kaplanmei
analysi
logrank
breslow
test
c
lung
index
assess
determin
percent
lung
wet
weight
g
bodi
weight
g
lung
index
lung
wet
weight
g
bodi
weight
g
day
pi
level
lung
homogen
determin
qrtpcr
assay
day
pi
n
e
f
iav
replic
viral
titter
lung
determin
qrtpcr
tcid
assay
day
pi
n
data
shown
mean
sd
p
compar
nc
dmso
viru
group
p
compar
pc
dmso
viru
oseltamivir
group
p
compar
omt
mgkgday
group
fight
iav
infect
tradit
chines
medicin
tcm
play
import
role
swine
flu
outbreak
chines
govern
releas
document
entitl
recommend
scheme
pandem
influenza
diagnos
treatment
recommend
four
antiflu
tcm
prescript
chines
nation
health
famili
plan
commiss
also
releas
relat
document
diagnos
treatment
flu
respect
separ
recommend
five
tcm
prescript
past
decad
alway
devot
research
antiiav
drug
screen
tcm
recent
construct
seri
luciferas
report
plasmid
base
gene
promot
signal
pathway
screen
sever
tcm
excel
antiiav
activ
sophora
root
one
investig
previou
research
relat
literatur
find
sophora
root
major
activ
compound
omt
use
treatment
chronic
viral
hepat
clinic
mani
year
moreov
pandem
sever
acut
respiratori
syndrom
sar
chines
bureau
scienc
technolog
announc
composit
sophora
japonica
inject
mainli
contain
omt
distinct
effect
treatment
sar
display
magic
power
omt
treat
system
inflammatori
respons
specul
omt
inhibit
iav
infect
may
directli
util
fight
iav
clinic
initi
expect
omt
realli
inhibit
replic
iav
includ
fight
iav
infect
tradit
chines
medicin
tcm
play
import
role
swine
flu
outbreak
chines
govern
releas
document
entitl
recommend
scheme
pandem
influenza
diagnos
treatment
recommend
four
antiflu
tcm
prescript
chines
nation
health
famili
plan
commiss
also
releas
relat
document
diagnos
treatment
flu
respect
separ
recommend
five
tcm
prescript
past
decad
alway
devot
research
antiiav
drug
screen
tcm
recent
construct
seri
luciferas
report
plasmid
base
gene
promot
signal
pathway
screen
sever
tcm
excel
antiiav
activ
sophora
root
one
investig
previou
research
relat
literatur
find
sophora
root
major
activ
compound
omt
use
treatment
chronic
viral
hepat
clinic
mani
year
moreov
pandem
sever
acut
respiratori
syndrom
sar
chines
bureau
scienc
technolog
announc
composit
sophora
japonica
inject
mainli
contain
omt
distinct
effect
treatment
sar
display
magic
power
omt
treat
system
inflammatori
respons
specul
omt
inhibit
iav
infect
may
directli
util
fight
iav
clinic
initi
expect
omt
realli
inhibit
replic
iav
includ
vitro
vivo
among
belong
human
iav
belong
avian
influenza
viru
explor
mechan
action
omt
iav
infect
although
tlr
signal
pathway
play
import
role
innat
immun
viru
infect
activ
signal
pathway
report
requir
iav
prolifer
last
activ
tlr
pathway
even
support
iav
replic
detriment
iavinduc
acut
pneumonia
present
studi
find
omt
significantli
decreas
express
gene
iav
infect
preliminarili
specul
omt
may
inhibit
iav
prolifer
iav
viral
pneumonia
via
inhibit
tlr
signal
pathway
activ
downstream
cascad
tlr
signal
pathway
mapk
also
report
essenti
iav
infect
report
activ
pathway
support
iav
infect
inhibit
akt
suppress
iav
entri
iav
rnp
nuclear
export
pleschka
et
al
show
activ
rafmekerk
signal
prerequisit
iav
replic
blockad
erk
pathway
retard
rnp
export
reduc
viru
titer
marjuki
h
et
al
show
iavinduc
activ
erk
requir
fusion
iav
viral
particl
target
cell
mediat
vatpasedepend
intracellular
ph
chang
guo
b
et
al
show
mapk
key
determin
viru
entri
tissu
tropism
activ
signal
also
prerequisit
iav
infect
inhibitor
specif
diminish
iav
vrna
transcript
crna
promot
reduc
vrna
synthesi
result
shown
omt
significantli
decreas
iavinduc
activ
akt
mapk
pathway
may
impli
signal
pathway
may
also
implic
antiiav
activ
omt
determin
import
signal
pathway
antiiav
activ
omt
activ
signal
pathway
use
present
studi
result
show
mapk
activ
significantli
counteract
antiiav
activ
omt
includ
iavinduc
cpe
iav
replic
activ
show
figur
think
omtinhibit
iav
replic
may
inhibit
mapk
signal
pathway
aforement
pathway
prove
essenti
iav
replic
iav
infect
also
induc
abnorm
elev
express
inflammatori
cytokin
mmp
report
contribut
sever
lung
injuri
also
promot
iav
prolifer
respiratori
tract
omt
wellknown
strong
immunosuppress
agent
determin
effect
omt
express
inflammatori
cytokin
mmp
find
omt
significantli
suppress
iavinduc
releas
moreov
report
iavinduc
releas
mapkand
specul
inhibit
omt
iavinduc
product
inflammatori
cytokin
may
least
part
via
inhibit
mapk
pathway
fact
report
omt
inhibit
activ
pathway
reduc
releas
inflammatori
mediat
fan
hg
et
al
report
omt
protect
brain
damag
downregul
pathway
wen
jb
et
al
indic
omt
improv
intestin
epitheli
barrier
function
inhibit
signal
pathway
ccl
induc
cirrhot
rat
dong
xq
et
al
report
omt
inhibit
phosphoryl
erk
jnk
mapk
suppress
nuclear
transloc
decreas
mrna
product
ino
final
inhibit
product
lpsstimul
microgli
cell
dosedepend
manner
final
vivo
test
show
omt
inhibit
iavinduc
loss
bodi
weight
increas
surviv
rate
decreas
pulmonari
edema
transcript
inflammatori
cytokin
pulmonari
viral
load
improv
histopatholog
chang
fact
previou
studi
determin
effect
omt
iav
infect
lower
concentr
find
omt
inhibit
iav
infect
vitro
vivo
carri
present
studi
higher
concentr
vitro
vivo
addit
omt
also
report
abl
attenu
oleic
acidinduc
ali
mice
cecal
ligat
punctureinduc
septic
shock
rat
show
omt
possess
excel
activ
inhibit
system
inflammatori
respons
addit
antiinflammatori
drug
divid
steroid
nonsteroid
antiinflammatori
drug
highdos
steroid
antiinflammatori
drug
usual
employ
treat
ali
ard
often
caus
seriou
side
effect
osteoporosi
vascular
necrosi
omt
exert
antiinflammatori
effect
independ
pituitaryadren
system
specul
omt
may
advantag
treat
aliard
steroid
antiinflammatori
drug
oxymatrin
omt
c
viru
stock
iav
strain
prepar
mdck
cell
embryon
egg
viru
titer
determin
plaqu
format
assay
cytotox
omt
mdck
cell
determin
mtt
assay
concentr
omt
requir
lower
cell
viabil
cc
calcul
use
origin
softwar
experi
iav
perform
biosafeti
level
laboratori
construct
promot
luciferas
report
plasmid
human
trif
gene
human
promot
promot
promot
promot
promot
promot
promot
trif
promot
promot
amplifi
pfu
dna
polymeras
invitrogen
use
cell
genom
dna
templat
pcr
product
clone
vector
name
ptrifluc
respect
primer
present
tabl
construct
verifi
doubl
enzym
digest
figur
dna
sequenc
assay
report
plasmid
purchas
beyotim
institut
biotechnolog
shanghai
china
cell
seed
plate
h
transfect
mention
plasmid
renilla
luciferas
report
plasmid
intern
control
use
lipofectamin
reagent
invitrogen
h
c
co
cell
wash
phosphat
buffer
salin
pb
infect
iav
multipl
infect
moi
adsorpt
h
cell
wash
time
pb
grown
drugcontain
viru
growth
medium
vgm
mem
tpcktrypsin
wv
bovin
serum
albumin
incub
h
luciferas
activ
determin
follow
instrument
luciferas
report
assay
kit
bd
bioscienc
clontech
result
present
fold
chang
normal
renilla
luciferas
activ
dmso
use
group
dissolv
drug
viral
titer
determin
plaqu
format
assay
previous
report
plaqu
inhibit
assay
also
perform
previous
report
briefli
cell
infect
iav
moi
meanwhil
treat
without
differ
concentr
omt
h
adsorpt
wash
pb
time
vgm
medium
without
omt
ad
h
cell
lyse
freez
thaw
centrifug
g
min
c
supernat
collect
viral
titer
determin
plaqu
format
assay
timeofaddit
assay
contain
four
test
perform
previous
report
direct
inactiv
assay
infect
iav
viru
incub
vgm
medium
contain
omt
h
iav
virion
gather
ultrafiltr
wash
pb
time
use
infect
mdck
cell
cultur
h
b
influenceoncel
assay
infect
mdck
cell
incub
vgm
medium
contain
omt
h
cell
wash
pb
time
infect
normal
iav
cultur
h
c
influenceonviraladsorpt
assay
viral
adsorpt
h
omt
ad
adsorpt
cell
wash
pb
time
cultur
normal
vgm
medium
h
differenttimepoint
post
infect
pi
assay
iav
infect
omt
ad
h
pi
respect
cultur
h
pi
moi
dmso
use
neg
control
nc
h
cell
lysat
gather
viral
titer
determin
plaqu
format
assay
stock
solut
iav
first
serial
dilut
vgm
medium
mdck
cell
seed
plate
h
infect
iav
h
tcid
calcul
follow
method
reed
muench
antivir
activ
also
evalu
srb
method
briefli
mdck
cell
seed
plate
ml
viru
suspens
tcid
ml
medium
contain
test
drug
ad
h
wash
c
aceton
ad
remov
aceton
plate
dri
ad
wv
srb
wash
plate
dri
ad
mm
trisbas
solut
od
read
nm
three
well
use
neg
virusinfect
nondrugtr
mock
control
noninfect
nondrugtr
dmso
use
group
percent
protect
omt
posit
relat
cell
viabil
calcul
follow
omttreat
group
group
n
mice
infect
intranas
mld
iav
virus
volum
treat
omt
mgkgday
mgkgday
oral
gavag
respect
dmso
vv
oseltamivir
omt
given
twice
day
interv
day
start
h
randomli
group
viru
exposur
bodi
weight
symptom
surviv
ten
mice
group
n
monitor
daili
day
viru
inocul
day
pi
anoth
six
mice
group
n
euthan
cervic
disloc
lung
index
assess
determin
percent
lung
wet
weight
g
bodi
weight
g
lung
index
lung
wet
weight
g
bodi
weight
g
collect
lung
separ
two
set
right
lung
fix
formalin
left
lung
frozen
c
left
lung
homogen
ml
cold
mem
medium
total
protein
level
measur
use
biorad
protein
assay
kit
viral
titer
target
protein
determin
tcid
elisa
qrtpcr
assay
unit
correct
amount
protein
examin
patholog
chang
right
side
lung
embed
paraffin
section
haematoxylin
eosin
h
e
stain
sever
histolog
chang
score
accord
semiquantit
score
system
show
supplement
materi
method
statist
signific
comparison
treat
group
assess
student
ttest
oneway
anova
post
hoc
dunnett
test
kaplanmei
analysi
logrank
breslow
test
use
softwar
valu
express
mean
standard
deviat
sd
p
valu
consid
statist
signific
omt
decreas
iavinduc
express
phosphoryl
mapk
nuclear
transloc
mapk
activ
antagon
antiiav
activ
omt
specul
antiiav
activ
omt
may
relat
abil
inhibit
iavinduc
activ
mapk
pathway
figur
final
base
result
studi
peopl
research
think
omt
promis
drug
treat
iav
infect
iavinduc
pneumonia
omttreat
group
group
n
mice
infect
intranas
iav
virus
volum
treat
omt
mgkgday
mgkgday
oral
gavag
respect
dmso
vv
oseltamivir
omt
given
twice
day
interv
day
start
h
randomli
group
viru
exposur
bodi
weight
symptom
surviv
ten
mice
group
n
monitor
daili
day
viru
inocul
day
pi
anoth
six
mice
group
n
euthan
cervic
disloc
lung
index
assess
determin
percent
lung
wet
weight
g
bodi
weight
g
lung
index
lung
wet
weight
g
bodi
weight
g
collect
lung
separ
two
set
right
lung
fix
formalin
left
lung
frozen
left
lung
homogen
ml
cold
mem
medium
total
protein
level
measur
use
biorad
protein
assay
kit
viral
titer
target
protein
determin
elisa
qrtpcr
assay
unit
correct
amount
protein
examin
patholog
chang
right
side
lung
embed
paraffin
section
haematoxylin
eosin
h
e
stain
sever
histolog
chang
score
accord
semiquantit
score
system
show
supplement
materi
method
statist
signific
comparison
treat
group
assess
student
ttest
oneway
anova
post
hoc
dunnett
test
kaplanmei
analysi
logrank
breslow
test
use
softwar
valu
express
mean
standard
deviat
sd
p
valu
consid
statist
signific
omt
decreas
iavinduc
express
phosphoryl
mapk
nuclear
transloc
mapk
activ
antagon
antiiav
activ
omt
specul
antiiav
activ
omt
may
relat
abil
inhibit
iavinduc
activ
mapk
pathway
figur
final
base
result
studi
peopl
research
think
omt
promis
drug
treat
iav
infect
iavinduc
pneumonia
figur
potenti
mechan
omt
inhibit
iav
infect
iavinduc
pneumonia
iav
infect
induc
highexpress
phosphoryl
mapk
nuclear
transloc
essenti
iav
prolifer
express
inflammatori
cytokin
mmp
final
lead
aliard
antiiav
activ
omt
relat
abil
inhibit
iavinduc
activ
mapk
pathway
bar
repres
inhibit
arrowhead
repres
activ
promot
figur
potenti
mechan
omt
inhibit
iav
infect
iavinduc
pneumonia
iav
infect
induc
highexpress
phosphoryl
mapk
nuclear
transloc
essenti
iav
prolifer
express
inflammatori
cytokin
mmp
final
lead
aliard
antiiav
activ
omt
relat
abil
inhibit
iavinduc
activ
mapk
pathway
bar
repres
inhibit
arrowhead
repres
activ
promot
